Treatment
Medication clinical trials
We’re tracking 7,450 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT05792033Recruiting
Registry for early T1 bladder cancer after repeat bladder surgery
This study follows people with newly diagnosed early bladder cancer (T1) to better understand outcomes and guide follow-up care. You may be able to join if your cancer is confirmed after a second look bladder procedure and scans show no spread.
ViennaAges 18–90 - NCT06533592Recruiting
Bile duct connection technique in liver transplant
This study compares two ways of connecting the bile duct during a liver transplant to see which leads to a smoother recovery. It is for adults having a planned first transplant from a deceased donor.
Warsaw, Masovian VoivodeshipAges 18–75 - NCT07127354RecruitingPhase 4
GLP-1 medications and colonoscopy prep quality
This study tests whether a special bowel preparation plan works better for people taking GLP-1 or GIP medications (like Ozempic, Mounjaro) before a colonoscopy. It aims to improve the quality of the bowel cleaning so doctors can see the colon more clearly.
Cleveland, FloridaAges 18 years+ - NCT06330090Recruiting
Thinking skills development in young children
This study looks at how thinking skills like memory, attention, and problem-solving grow in healthy children ages 7 to 10. It will help researchers understand normal brain development. There is an optional brain imaging part for children ages 8 to 10.
NijmegenAges 7–13 - NCT06447428Recruiting
Cognitive changes in late-life depression: a one-year study
This study follows older adults with depression to see how their thinking and memory might change over one year. It may help understand if early treatment can protect brain health.
Fuzhou, FujianAges 60 years+ - NCT06336863Enrolling by invitation
DNA test to help kidney transplant patients switch to a single anti-rejection drug
This trial uses DNA testing and gene expression profiling to see if kidney transplant recipients can safely switch to a belatacept-only immunosuppression regimen. The goal is to simplify your anti-rejection drugs while keeping your kidney healthy.
Dallas, TexasAges 18 years+ - NCT06369584Recruiting
Prone Position for Children on ECMO with Severe ARDS
This trial tests if lying face-down (prone position) helps children with severe ARDS who are already on ECMO, a machine that supports the heart and lungs. It aims to see if this position improves recovery.
Beijing, Beijing MunicipalityAges 1 month–18 years - NCT06387381RecruitingEarly Phase 1
PET scan for PSMA/FAP-positive cancer
This trial tests a special PET scan using a tracer that attaches to certain markers (PSMA and FAP) found on some cancers. It aims to help doctors see where the cancer is, possibly leading to better treatment decisions.
Chongqing, Chongqing MunicipalityAges 18 years+ - NCT06149195Enrolling by invitation
Heart scan for managing heart failure
This trial tests a special heart scan (18F-MFBG) to see if it can help doctors better manage heart failure. You may qualify if you have chronic heart failure with a weak heart pump and are planning to get a defibrillator.
Chengdu, SichuanAges 18–80 - NCT07655921Recruiting
Enhanced recovery after knee replacement surgery
This trial tests a special care plan called ERAS to help people recover faster after total knee replacement. It compares this plan to standard care to see if it reduces hospital stay and improves recovery.
Karachi, SindhAges 50–70 - NCT03566797Recruiting
Study in ICU patients with prolonged breathing support
This study looks at outcomes in adults who need breathing support for at least 5 days in intensive care. It may help clinicians better understand and manage complications in this critical illness group.
GrazAges 18 years+ - NCT07162948Recruiting
Home monitoring technology for ICU recovery
This study tests a smart technology box that helps monitor your health at home after a stay in the ICU. It may help you and your doctors keep track of your recovery more easily.
Leiden, South HollandAges 18 years+ - NCT06387810RecruitingPhase 2
Chemo before and after surgery for borderline resectable pancreatic cancer
This trial tests a combination of chemotherapy drugs (irinotecan liposome, 5-FU, leucovorin, and oxaliplatin) given before and after surgery for people with pancreatic cancer that is on the border of being removable. The goal is to see if this treatment helps shrink the tumor and improve outcomes.
Beijing, Beijing MunicipalityAges 18–110 - NCT06447740Recruiting
Stent vs. medication for narrowed kidney artery
This trial compares placing a tiny mesh tube (stent) to open the narrowed kidney artery versus continuing blood pressure medicines alone. It is for people whose high blood pressure is hard to control even with multiple medications and who have a blockage in the kidney artery that can be treated.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06148025RecruitingPhase 4
Do antibiotics affect vaccine responses?
This study looks at whether taking a short course of antibiotics can change how your body responds to two vaccines (BCG and yellow fever). It may help researchers find ways to make vaccines work better.
Adelaide, South AustraliaAges 18–35 - NCT06396247RecruitingPhase 2/Phase 3
Daily leg exercises to improve walking
This study tests a simple daily leg-strengthening routine to see if it helps people who have trouble walking short distances. You'll do easy resistance exercises at home, which might make it easier to walk and move around.
Hershey, PennsylvaniaAges 65 years+ - NCT00900471Recruiting
Store tissue samples from surgery for suspected solid tumors
This study collects and stores small tissue samples from people who have surgery or a biopsy for a suspected solid (non-blood) tumor. It helps researchers study these cancers for future testing and research.
Winston-Salem, North CarolinaAges 18–120 - NCT07650396RecruitingPhase 3
Steroid Injections for Long-Term Achilles Tendon Pain
This study tests whether steroid injections can help people with chronic Achilles tendon pain (the tendon at the back of your heel) who haven't improved with physical therapy and exercise. The injection is designed to reduce inflammation and pain in the middle part of the tendon.
RotterdamAges 18–65 - NCT06928922RecruitingEarly Phase 1
Inhaled mRNA vaccine for advanced lung cancer and lung metastases
This trial tests an inhaled dry powder vaccine that uses mRNA to help your immune system target cancer cells in the lungs. It is for people with advanced lung cancer or solid tumors that have spread to the lungs, who have already tried standard treatments.
BeijingAges Up to 99 years - NCT05831475Recruiting
Program to reduce loneliness with intergenerational video support
This trial tests an intergenerational program (between younger and older adults) to help reduce loneliness and social isolation. It asks you to join activities using video on an internet-connected device and to be able to follow study steps safely at home.
Beverly Hills, CaliforniaAges 18 years+ - NCT06375746Recruiting
Video to reduce anxiety before labor induction
This study tests if watching a short, personalized video before labor induction can help lower anxiety. The video explains what to expect, so you may feel more prepared and less nervous.
HolonAges 18–45 - NCT07649239Recruiting
Gum Grafting Methods for Dental Implants in Front Teeth
This trial compares two techniques to improve the appearance and health of gum tissue around dental implants in your front teeth. One uses a special blood product (PRF), and the other uses a traditional gum graft. The goal is to see which gives better-looking results.
Ajman, Ajman EmirateAges 20–70 - NCT06843447RecruitingPhase 1/Phase 2
Study of Raludotatug Deruxtecan for Ovarian Cancer
This study tests a new drug called raludotatug deruxtecan for people with ovarian cancer that has come back. It's designed for those whose cancer is either sensitive or resistant to platinum chemotherapy, and who have had 1-3 prior treatments.
New Haven, ConnecticutAges 18 years+ - NCT06395870RecruitingPhase 1
Dual-target cell therapy for returning B-cell lymphoma
This trial tests a new cell therapy that targets two proteins (CD19 and CD20) found on certain lymphoma cells. It is for patients whose B-cell non-Hodgkin lymphoma has come back or not responded to at least two prior treatments. The goal is to see if this therapy can help control the cancer.
Hefei, AnhuiAges 18–75
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,450 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.